ExodusPoint Capital Management, LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2023$209
-57.3%
13,285
-55.3%
0.00%
-50.0%
Q1 2023$490
+5.2%
29,705
-0.5%
0.00%
-42.9%
Q4 2022$466
-99.9%
29,851
+25.5%
0.01%
+75.0%
Q2 2022$334,000
-26.8%
23,779
-25.3%
0.00%
-33.3%
Q1 2022$456,000
-42.6%
31,842
-45.3%
0.01%
-25.0%
Q4 2021$794,000
+50.7%
58,256
+81.0%
0.01%
+14.3%
Q3 2021$527,000
-8.0%
32,193
+2.6%
0.01%
-12.5%
Q1 2021$573,000
-24.6%
31,363
-24.9%
0.01%
+14.3%
Q4 2020$760,000
+36.2%
41,735
+33.4%
0.01%
-36.4%
Q3 2020$558,000
+10.9%
31,285
+22.7%
0.01%
+22.2%
Q4 2019$503,00025,5060.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders